Poly-ε-caprolactone based formulations for drug delivery and tissue engineering: A review

Journal of Controlled Release

Volumn 158, Issue 1, 2012, Pages 15-33

  Dash, Tapan K ^a   Konkimalla, V Badireenath ^a  

^a NATIONAL INSTITUTE OF SCIENCE EDUCATION AND RESEARCH   (India)

Author keywords

Fibers; Films; Micelles; Microspheres; Nanoparticles; Scaffold

Indexed keywords

CAPROLACTONE; DRUG DELIVERY SYSTEM; PHARMACOKINETIC PARAMETERS; SYNTHETIC BIODEGRADABLE POLYMERS; THERAPEUTIC EFFICACY; TISSUE ENGINEERING APPLICATIONS;

BIODEGRADABLE POLYMERS; DRUG DELIVERY; FIBERS; FILM PREPARATION; FILMS; MICELLES; MICROSPHERES; NANOPARTICLES; SCAFFOLDS;

SCAFFOLDS (BIOLOGY);

CAMPTOTHECIN; CISPLATIN; DEXAMETHASONE ACETATE; DICLOFENAC; DOXORUBICIN; ELLAGIC ACID; ETOPOSIDE; FISH OIL; GEMCITABINE; GRISEOFULVIN; HONOKIOL; INDOMETACIN; INSULIN; LIPOPLEX; MAGNETITE; MICROSPHERE; MITOMYCIN C; NANOPARTICLE; NIMODIPINE; OIL SCARLET; PACLITAXEL; POLYCAPROLACTONE; SIALOPROTEIN; TAMOXIFEN; TAMOXIFEN CITRATE; TEGAFUR; TETRACYCLINE; TIBOLONE; TISSUE SCAFFOLD; UNINDEXED DRUG; DRUG CARRIER; POLYESTER;

BIODEGRADATION; BIOFILM; COMPOSITE MATERIAL; DEGRADATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; HUMAN; HYDROGEL; MICELLE; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; ANIMAL; CHEMISTRY; METHODOLOGY;

ANIMALS; DRUG CARRIERS; HUMANS; HYDROGELS; MICELLES; MICROSPHERES; NANOPARTICLES; POLYESTERS; TISSUE ENGINEERING;

EID: 84861651995     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.09.064     Document Type: Review

References (171)

1. C.T. Vogelson Advances in drug delivery systems Mod. Drug Discovery 4 2001 49 50
2. A. Raizada, A. Bandari, and B. Kumar Polymers in drug delivery: a review Int. J. Pharm. Res. Dev. 2 8 2010 9 20
3. J.L. Lowery, N. Datta, and G.C. Rutledge Effect of fiber diameter, pore size and seeding method on growth of human dermal fibroblasts in electrospun poly(epsilon-caprolactone) fibrous mats Biomaterials 31 3 2009 491 504
4. J. Venugopal, S. Low, A.T. Choon, and S. Ramakrishna Interaction of cells and nanofiber scaffolds in tissue engineering J. Biomed. Mater. Res. B Appl. Biomater. 84 1 2008 34 48
5. C.S. Szot, C.F. Buchanan, P. Gatenholm, M.N. Rylander, and J.W. Freeman Investigation of cancer cell behavior on nanofibrous scaffolds Mater. Sci. Eng. C 31 2011 37 42
6. V.R. Sinha, K. Bansal, R. Kaushik, R. Kumria, and A. Trehan Poly-epsilon-caprolactone microspheres and nanospheres: an overview Int. J. Pharm. 278 1 2004 1 23
7. M. Hakkarainen, and A.C. Albertsson Heterogeneous biodegradation of polycaprolactone - low molecular weight products and surface changes Macromol. Chem. Phys. 203 2002 1357 1363
8. M.A. Woodruff, and D.W. Hutmacher The return of a forgotten polymer-polycaprolactone in the 21st century Prog. Polym. Sci. 35 2010 1217 1256
9. J.M. Estelle, A. Vidaurre, J.M.M. Duenas, and I.C. Cortazar Physical characterization of polycaprolactone scaffolds J. Mater. Sci. Mater. Med. 19 2008 189 195
10. C.B. Liu, C.Y. Gong, M.J. Huang, J.W. Wang, Y.F. Pan, Y.D. Zhang, G.Z. Li, M.L. Gou, K. Wang, M.J. Tu, Y.Q. Wei, and Z.Y. Qian Thermoreversible gel-sol behavior of biodegradable pcl-peg-pcl triblock copolymer in aqueous solutions J. Biomed. Mater. Res. B Appl. Biomater. 84B 2008 165 175
11. S. Kalambur, and S.S.H. Rizvi Rheological behavior of starch-polycaprolactone (pcl) nanocomposite melts synthesized by reactive extrusion Polym. Eng. Sci. 2006 650 658 (Pubitemid 43734474)
12. Y. Wan, X. Lu, S. Dalai, and J. Zhang Thermophysical properties of polycaprolactone/chitosan blend membranes Thermochim. Acta 487 2009 33 38
13. Z. Ma, A. Haddadi, O. Molavi, A. Lavasanifar, R. Lai, and J. Samuel Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin J. Biomed. Mater. Res. A 86 2 2008 300 310 (Pubitemid 351969628)
14. F.A. Sheikh, N.A. Barakat, M.A. Kanjwal, S. Aryal, M.S. Khil, and H.Y. Kim Novel self-assembled amphiphilic poly(epsilon-caprolactone)-grafted- poly(vinyl alcohol) nanoparticles: hydrophobic and hydrophilic drugs carrier nanoparticles J. Mater. Sci. Mater. Med. 20 3 2009 821 831
15. C. Chen, G. Cai, H. Zhang, H. Jiang, and L. Wang Chitosan-poly(epsilon- caprolactone)-poly(ethylene glycol) graft copolymers: synthesis, self-assembly, and drug release behavior J. Biomed. Mater. Res. A 96 1 2010 116 124
16. K. Gorna, and S. Gogolewski In vitro degradation of novel medical biodegradable aliphatic polyurethanes based on epsilon-caprolactone and pluronics with various hydrophilicities Polym. Degrad. Stab. 75 2002 113 122 (Pubitemid 33142202)
17. M. Pulkkinena, M. Malin, J. Böhmd, T. Tarvainen, T. Wirth, J. Seppälä, and K. Järvinen In vivo implantation of 2,2'-bis(oxazoline)-linked poly-epsilon-caprolactone: proof for enzyme sensitive surface erosion and biocompatibility Eur. J. Pharm. Sci. 2009
18. M.J. Jenkins, and K.L. Harrison The effect of molecular weight on the crystallization kinetics of polycaprolactone Polym. Adv. Technol. 17 2006 474 478 (Pubitemid 44263204)
19. D.R. Chen, J.Z. Bei, and S.G. Wang Polycaprolactone microparticles and their biodegradation Polym. Degrad. Stab. 67 2000 455 459 (Pubitemid 32212633)
20. J.S. Chawla, and M.M. Amiji Biodegradable poly(epsilon-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen Int. J. Pharm. 249 1-2 2002 127 138 (Pubitemid 35333439)
21. A. Hoshino, and Y. Isono Degradation of aliphatic polyester films by commercially available lipases with special reference to rapid and complete degradation of poly(L-lactide) film by lipase PL derived from Alcaligenes sp Biodegradation 13 2002 141 147 (Pubitemid 35257062)
22. K. Herzog, R.-J. Muller, and W.-D. Deckwer Mechanism and kinetics of the enzymatic hydrolysis of polyester nanoparticles by lipases Polym. Degrad. Stab. 91 2006 2486 2498 (Pubitemid 43963156)
23. A. Baji, S.-C. Wong, T.S. Srivatsan, G.O. Njus, and G. Mathur Processing methodologies for polycaprolactone-hydroxyapatite composites: a review Mater. Manuf. Processes 20 2006 211 218 (Pubitemid 43328841)
24. P.A. Burke, L.A. Klumb, J.D. Herberger, X.C. Nguyen, R.A. Harrell, and M. Zordich Poly(lactide-co-glycolide) microsphere formulations of darbepoetin alfa: spray drying is an alternative to encapsulation by spray-freeze drying Pharm. Res. 21 3 2004 500 506 (Pubitemid 38338986)
25. X. Wang, Y. Wang, K. Wei, N. Zhao, S. Zhang, and J. Chen Drug distribution within poly(epsilon-caprolactone) microspheres and in vitro release J. Mat Proc Technol 209 2009 348 354
26. M.H. Perez, C. Zinutti, A. Lamprecht, N. Ubrich, A. Astier, M. Hoffman, R. Bodmeier, and P. Maincent The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug J. Control. Release 65 3 2000 429 438 (Pubitemid 30122944)
27. N.K. Varde, and D.W. Pack Microspheres for controlled release drug delivery Expert Opin. Biol. Ther. 4 1 2004 35 51 (Pubitemid 38057265)
28. D.V. Ramesh Comparison of oil-in-oil, water-in-oil-in-water and melt encapsulation techniques for the preparation of controlled release b12 poly (epsilon-caprolactone) microparticles Trends Biomater. Artif. Organs 23 1 2009 21 33
29. D.V. Ramesh Development of a process for microencapsulation of a model protein with poly (epsilon-caprolactone) using a modified w/o/o technique Trends Biomater. Artif. Organs 23 1 2009 46 54
30. J. Lee, S. Oh, M.K. Joo, and B. Jeong Solvent-free preparation of caprolactone oligomer microspheres J. Phys. Chem. Solids 69 2008 1596 1599 (Pubitemid 351671760)
31. O.R. Davies, A.L. Lewis, M.J. Whitaker, H. Tai, K.M. Shakesheff, and S.M. Howdle Applications of supercritical CO2 in the fabrication of polymer systems for drug delivery and tissue engineering Adv. Drug Deliv. Rev. 60 3 2008 373 387
32. F. Maulvi, V.T. Thakkar, T.G. Soni, M.C. Gohel, and T.R. Gandhi Supercritical fluid technology: a promising approach to enhance the drug solubility J. Pharm. Sci. Res. 1 4 2009 1 14
33. E.A. Reverchon, R.,.S. Cardea, and G.D. Porta Supercritical fluids processing of polymers for pharmaceutical and medical applications J. Supercrit. Fluids 47 2009 484 492
34. S.P. Nalawade, F. Picchioni, and L.P.B.M. Janssen Supercritical carbon dioxide as a green solvent for processing polymer melts: processing aspects and applications Prog. Polym. Sci. 31 2006 19 43 (Pubitemid 43136696)
35. B.K. Kim, S.J. Hwang, J.B. Park, and H.J. Park Characteristics of felodipine-located poly(epsilon-caprolactone) microspheres J. Microencapsul. 22 2 2005 193 203
36. R.C. Mundargi, S. Srirangarajan, S.A. Agnihotri, S.A. Patil, S. Ravindra, S.B. Setty, and T.M. Aminabhavi Development and evaluation of novel biodegradable microspheres based on poly(d, l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies J. Control. Release 119 1 2007 59 68 (Pubitemid 46561539)
37. V. Natarajan, N. Krithica, B. Madhan, and P.K. Sehgal Formulation and evaluation of quercetin polycaprolactone microspheres for the treatment of rheumatoid arthritis J. Pharm. Sci. 100 1 2011 195 205
38. H.J. Kim, T.H. Kim, K.C. Kang, H.B. Pyo, and H.H. Jeong Microencapsulation of rosmarinic acid using polycaprolactone and various surfactants Int. J. Cosmet. Sci. 32 3 2010 185 191
39. E.R. Balmayor, K. Tuzlakoglu, H.S. Azevedo, and R.L. Reis Preparation and characterization of starch-poly-epsilon-caprolactone microparticles incorporating bioactive agents for drug delivery and tissue engineering applications Acta Biomater. 5 4 2009 1035 1045
40. V. Sankavarapu, and J. Aukunuru Development and evaluation of zero order sustained release matrix type transdermal films of ibuprofen J. Global Pharma Tech. 2 2 2010 51 58
41. C.R. Bonepally, J. Aukunuru, N.R. Yellu, and M.R. Vanga Fabrication and investigations on hepatoprotective activity of sustained release biodegradable piperine microspheres Int. J. Pharm. Sci. Nanotechnol. 1 1 2008 87 96
42. V.R. Sinha, and A. Trehan Development, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres as a depot system for parenteral delivery Drug Deliv. 15 6 2008 365 372
43. K. Vivek, L.H. Reddy, and R.S. Murthy Comparative study of some biodegradable polymers on the entrapment efficiency and release behavior of etoposide from microspheres Pharm. Dev. Technol. 12 1 2007 79 88 (Pubitemid 46902616)
44. J.C. Jeong, J. Lee, and K. Cho Effects of crystalline microstructure on drug release behavior of poly(epsilon-caprolactone) microspheres J. Control. Release 92 3 2003 249 258 (Pubitemid 38366148)
45. G. Li, Q. Cai, J. Bei, and S. Wang Morphology and levonorgestrel release behavior of polycaprolactone/poly(ethylene oxide)/polylactide tri-component copolymeric microspheres Polym. Adv. Technol. 14 2003 239 244 (Pubitemid 36619351)
46. M. Petitti, A.A. Barresi, and M. Vanni Controlled release of vancomycin from PCL microcapsules for an ophthalmic application Chem. Eng. Res. Des. 87 859-866 2009 859
47. S. Wang, S. Guo, and L. Cheng Disodium norcantharidate loaded poly(epsilon-caprolactone) microspheres I. Preparation and evaluation Int. J. Pharm. 350 1-2 2008 130 137
48. H.F. Florindo, S. Pandit, L.M. Goncalves, H.O. Alpar, and A.J. Almeida Streptococcus equi antigens adsorbed onto surface modified poly-epsilon- caprolactone microspheres induce humoral and cellular specific immune responses Vaccine 26 33 2008 4168 4177
49. A. Mukerjee, V.R. Sinha, and V. Pruthi Preparation and characterization of poly-ε-caprolactone particles for controlled insulin delivery J Biomed & Pharml Engg 1 1 2007 40 44
50. R.L. Sastre, M.D. Blanco, C. Teijo, R. Olmo, and J.M. Teijon Preparation and characterization of 5-fluorouracil-loaded poly(epsilon-caprolactone) microspheres for drug administration Drug Dev. Res. 63 2004 41 53 (Pubitemid 40189750)
51. H. Wu, S. Wang, H. Fang, X. Zan, J. Zhang, and Y. Wan Chitosan-polycaprolactone copolymer microspheres for transforming growth factor-beta1 delivery Colloids Surf. B Biointerfaces 82 2011 602 608
52. G. Hughes Nanostructure-mediated drug delivery Nanomed. Nanotechnol. Biol. Med. 1 2005 22 30 (Pubitemid 43963612)
53. A.H. Faraji, and P. Wipf Nanoparticles in cellular drug delivery Bioorg. Med. Chem. 17 8 2009 2950 2962
54. W.H. De Jong, and P.J. Borm Drug delivery and nanoparticles:applications and hazards Int. J. Nanomedicine 3 2 2008 133 149
55. D. Bhowmik, Chiranjib, R. Margret, and C.B. Jayakar Role of nanotechnology in novel drug delivery system J. Pharm. Sci. Technol. 1 1 2009 20 35
56. K. Park Nanotechnology: what it can do for drug delivery J. Control. Release 120 1-2 2007 1 3 (Pubitemid 46874626)
57. A. Kumari, S.K. Yadav, and S.C. Yadav Biodegradable polymeric nanoparticles based drug delivery systems Colloids Surf. B Biointerfaces 75 1 2009 1 18
58. C.P. Reis, R.J. Neufeld, A.J. Ribeiro, and F. Veiga Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles Nanomedicine 2 1 2006 8 21
59. V. Kumar, and R.K. Prudhomme Nanoparticle stability: processing pathways for solvent removal Chem. Eng. Sci. 64 2009 1358 1361
60. K. Sonaje, J.L. Italia, G. Sharma, V. Bhardwaj, K. Tikoo, and M.N. Kumar Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats Pharm. Res. 24 5 2007 899 908 (Pubitemid 46675391)
61. J.S. Rodrigues, N.S. Santos-Magalhaes, L.C. Coelho, P. Couvreur, G. Ponchel, and R. Gref Novel core(polyester)-shell(polysaccharide) nanoparticles: protein loading and surface modification with lectins J. Control. Release 92 1-2 2003 103 112 (Pubitemid 37130125)
62. R. Li, X. Li, L. Xie, D. Ding, Y. Hu, X. Qian, L. Yu, Y. Ding, X. Jiang, and B. Liu Preparation and evaluation of PEG-PCL nanoparticles for local tetradrine delivery Int. J. Pharm. 379 1 2009 158 166
63. S. Papadimitriou, and D. Bikiaris Novel self-assembled core-shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release J. Control. Release 138 2 2009 177 184
64. M.J. Choi, U. Ruktanonchai, A. Soottitantawat, and S.G. Min Morphological characterization of encapsulated fish oil with beta-cyclodextrin and polycaprolactone Food Res. Int. 42 2009 989 997
65. C. Damge, P. Maincent, and N. Ubrich Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats J. Control. Release 117 2 2007 163 170 (Pubitemid 46161872)
66. J. Yang, S.B. Park, H.G. Yoon, Y.M. Huh, and S. Haam Preparation of poly epsilon-caprolactone nanoparticles containing magnetite for magnetic drug carrier Int. J. Pharm. 324 2 2006 185 190 (Pubitemid 44528914)
67. J.L. Arias, M. Lopez-Viota, E. Saez-Fernandez, and M.A. Ruiz Formulation and physicochemical characterization of poly(epsilon-caprolactone) nanoparticles loaded with ftorafur and diclofenac sodium Col Surf B Biointerfaces 75 1 2009 204 208
68. M. Snehalatha, K. Venugopal, and R.N. Saha Etoposide-loaded plga and pcl nanoparticles i: preparation and effect of formulation variables Drug Deliv. 15 5 2008 267 275
69. E.P. Segundo, A. Ganem-Quintanar, J. Rafael Garibay-Bermudez, J. Juan Escobar-Chavez, M. Lopez-Cervantes, and D. Quintanar-Guerrero Preparation of nanoparticles by solvent displacement using a novel recirculation system Pharm. Dev. Technol. 11 4 2006 493 501 (Pubitemid 44852431)
70. R.C.R. Beck, S.S. Guterres, R.J. Freddo, C.B. Michalowski, I. Barcellos, and J.A.B. Funck Nanoparticles containing dexamethasone: physicochemical properties and anti-inflammatory activity Acta Farm. Bonaerense 22 1 2002 11 15
71. Y. Huang, L. Li, and Y. Fang Self-assembled particles of N-phthaloylchitosan-g-polycaprolactone molecular bottle brushes as carriers for controlled release of indometacin J. Mater. Sci. Mater. Med. 21 2 2009 557 565
72. E. Bilensoy, C. Sarisozen, G. Esendagli, A.L. Dogan, Y. Aktas, M. Sen, and N.A. Mungan Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors Int. J. Pharm. 371 1-2 2009 170 176
73. M. Gou, L. Zheng, X. Peng, K. Men, X. Zheng, S. Zeng, G. Guo, F. Luo, X. Zhao, L. Chen, Y. Wei, and Z. Qian Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro Int. J. Pharm. 375 1-2 2009 170 176
74. Z. Zili, S. Sfar, and H. Fessi Preparation and characterization of poly-epsilon-caprolactone nanoparticles containing griseofulvin Int. J. Pharm. 294 1-2 2005 261 267 (Pubitemid 40462340)
75. Y. Zhang, and R.X. Zhuo Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly (ethylene glycol) and polycaprolactone Biomaterials 26 33 2005 6736 6742 (Pubitemid 41021767)
76. L. Zhang, Y. Hu, X. Jiang, C. Yang, W. Lu, and Y.H. Yang Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co- lactide) nanoparticles and their biodistribution in mice J. Control. Release 96 1 2004 135 148 (Pubitemid 38438496)
77. Y. Hu, X. Jiang, Y. Ding, L. Zhang, C. Yang, J. Zhang, J. Chen, and Y. Yang Preparation and drug release behaviors of nimodipine-loaded poly(caprolactone)-poly(ethylene oxide)-polylactide amphiphilic copolymer nanoparticles Biomaterials 24 13 2003 2395 2404 (Pubitemid 36434059)
78. L. Shor, A. Darling, B. Starly, W. Sun, and S. Guceri Precision extruding deposition of composite polycaprolactone/hydroxyapatite scaffolds for bone tissue engineering Proc IEEE 31st Ann Northeast 2005 172 173 (Pubitemid 41731358)
79. G.A. Silva, P. Ducheyne, and R.L. Reis Materials in particulate form for tissue engineering. 1. Basic concepts J. Tissue Eng. Regen. Med. 1 1 2007 4 24
80. C.M. Agrawal, and R.B. Ray Biodegradable polymeric scaffolds for musculoskeletal tissue engineering J. Biomed. Mater. Res. 55 2 2001 141 150 (Pubitemid 32198496)
81. M. Martina, and D.W. Hutmacher Biodegradable polymers applied in tissue engineering research: a review Polym. Int. 56 2007 145 157 (Pubitemid 46165222)
82. M.I. Santos, R.E. Unger, R.A. Sousa, R.L. Reis, and C.J. Kirkpatrick Crosstalk between osteoblasts and endothelial cells co-cultured on a polycaprolactone-starch scaffold and the in vitro development of vascularization Biomaterials 30 26 2009 4407 4415
83. A.G. Mikos, and J.S. Temenoff Formation of highly porous biodegradable scaffolds for tissue engineering Electron. J. Biotechnol. 3 2 2000 1 6
84. V.V. Gaikwad, A.B. Patil, and M.V. Gaikwad Scaffolds for drug delivery in tissue engineering Int. J. Pharm. Sci. Nanotechnol. 1 2 2008 113 121
85. Y. Qian, X. Li, Y. Su, Q. Ke, and X. Mo Fabrication and characterization of polycaprolactone/chlorophyllin sodium copper salt nanofibrous mats from 2,2,2-trifluoroethanol solution by electrospinning Iran. Polym. J. 18 3 2009 265 274
86. A.R. Sarasam, A.I. Samli, L. Hess, M.A. Ihnat, and S.V. Madihally Blending chitosan with polycaprolactone: porous scaffolds and toxicity Macromol. Biosci. 7 9-10 2007 1160 1167 (Pubitemid 47485320)
87. D. Yao, A. Smith, P. Nagarajan, A. Vasquez, L. Dang, and G.R. Chaudhry Fabrication of polycaprolactone scaffolds using a sacrificial compression-molding process J. Biomed. Mater. Res. B Appl. Biomater. 77 2 2006 287 295 (Pubitemid 43667452)
88. S.H. Oh, I.K. Park, J.M. Kim, and J.H. Lee In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method Biomaterials 28 9 2007 1664 1671 (Pubitemid 46098965)
89. S.A. Abbah, C.X. Lam, D.W. Hutmacher, J.C. Goh, and H.K. Wong Biological performance of a polycaprolactone-based scaffold used as fusion cage device in a large animal model of spinal reconstructive surgery Biomaterials 30 28 2009 5086 5093
90. E.Y. Teo, S.Y. Ong, M.S. Chong, Z. Zhang, J. Lu, S. Moochhala, B. Ho, and S.H. Teoh Polycaprolactone-based fused deposition modeled mesh for delivery of antibacterial agents to infected wounds Biomaterials 32 1 2011 279 287
91. I. Gercek, R.S. Tigli, and M. Gumusderelioglu A novel scaffold based on formation and agglomeration of PCL microbeads by freeze-drying J. Biomed. Mater. Res. A 86 4 2008 1012 1022
92. S.M. Roosa, J.M. Kemppainen, E.N. Moffitt, P.H. Krebsbach, and S.J. Hollister The pore size of polycaprolactone scaffolds has limited influence on bone regeneration in an in vivo model J. Biomed. Mater. Res. A 92 1 2010 359 368
93. M. Quiquerez, M. Peroglio, L. Gremillard, J. Chevalier, L. Chazeau, C. Gauthier, T. Hamaide, and A. Bignon Improvement of the mechanical properties of calcium phosphate bone substitutes by polycaprolactone infiltration Key Eng. Mater. 361-363 2008 403 406
94. S. Jankong, and K. Srikulkit Preparation of polypropylene/hydrophobic silica nanocomposites J. Met. Mater Mine 18 2 2008 143 146
95. M. Avella, F. Bondioli, V. Cannillo, E. Di Pace, M.E. Errico, A.M. Ferrari, B. Focher, and M. Malinconico Poly(epsilon-caprolactone)-based nanocomposites: influence of compatibilization on properties of poly(epsilon-caprolactone)-silica nanocomposites Comp. Sci. Tech. 66 2006 886 894 (Pubitemid 43380454)
96. J. Wei, S.J. Heo, D.H. Kim, S.E. Kim, Y.T. Hyun, and J.-W. Shin Comparison of physical, chemical and cellular responses to nano- and micro-sized calcium silicate/poly(epsilon-caprolactone) bioactive composites J. Res. Soc. Interf. 5 2008 617 630 (Pubitemid 351589742)
97. R. Asmatulu, A. Fakhari, H.L. Wamocha, H.Y. Chu, Y.Y. Chen, M.M. Eltabey, H.H. Hamdeh, and J.C. Ho Drug-carrying magnetic nanocomposite particles for potential drug delivery systems J. Nanotechnol. 2009 1 6
98. B. Zhu, S.R. Bailey, and C. Mauli Agrawal Engineering calcium deposits on polycaprolactone scaffolds for intravascular applications using primary human osteoblasts J. Tissue Eng. Regen. Med. 5 4 2011 324 336
99. H. Yu, P.H. Wooley, and S.Y. Yang Biocompatibility of Poly-epsilon-caprolactone-hydroxyapatite composite on mouse bone marrow-derived osteoblasts and endothelial cells J. Orthop. Surg. Res. 4 2009 5
100. S. Singh, B.M. Wu, and J.C. Dunn The enhancement of VEGF-mediated angiogenesis by polycaprolactone scaffolds with surface cross-linked heparin Biomaterials 32 8 2010 2059 2069
101. C.E. Holy, M.S. Shoichet, and J.E. Davies Engineering three-dimensional bone tissue in vitro using biodegradable scaffolds: investigating initial cell-seeding density and culture period J. Biomed. Mater. Res. 51 3 2000 376 382 (Pubitemid 30452140)
102. H.H. Song, M.K. Yoo, H.S. Moon, Y.J. Choi, H.C. Lee, and C.S. Cho A novel polycaprolactone/hydroxyapatite scaffold for bone tissue engineering Key Eng. Mater. 342-343 2007 265 268
103. A. Andukuri, M. Kushwaha, A. Tambralli, J.M. Anderson, D.R. Dean, J.L. Berry, Y.D. Sohn, Y.S. Yoon, B.C. Brott, and H.W. Jun A hybrid biomimetic nanomatrix composed of electrospun polycaprolactone and bioactive peptide amphiphiles for cardiovascular implants Acta Biomater. 7 1 2011 225 233
104. B.W. Tillman, S.K. Yazdani, S.J. Lee, R.L. Geary, A. Atala, and J.J. Yoo The in vivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction Biomaterials 30 4 2009 583 588
105. S.G. Wise, M.J. Byrom, A. Waterhouse, P.G. Bannon, M.K. Ng, and A.S. Weiss A multilayered synthetic human elastin/polycaprolactone hybrid vascular graft with tailored mechanical properties Acta Biomater. 7 1 2011 295 303
106. D.R. Nisbet, A.E. Rodda, M.K. Horne, J.S. Forsythe, and D.I. Finkelstein Neurite infiltration and cellular response to electrospun polycaprolactone scaffolds implanted into the brain Biomaterials 30 27 2009 4573 4580
107. H. Cao, T. Liu, and S.Y. Chew The application of nanofibrous scaffolds in neural tissue engineering Adv. Drug Deliv. Rev. 61 12 2009 1055 1064
108. P. Wutticharoenmongkol, N. Sanchavanakit, P. Pavasant, and P. Supaphol Preparation and characterization of novel bone scaffolds based on electrospun polycaprolactone fibers filled with nanoparticles Macromol. Biosci. 6 1 2006 70 77 (Pubitemid 43082692)
109. C. Erisken, D.M. Kalyon, and H. Wang Functionally graded electrospun polycaprolactone and beta-tricalcium phosphate nanocomposites for tissue engineering applications Biomaterials 29 30 2008 4065 4073
110. P. Wutticharoenmongkol, N. Sanchavanakit, P. Pavasant, and P. Supaphol Novel bone scaffolds of electrospun polycaprolactone fibers filled with nanoparticles J. Nanosci. Nanotechnol. 6 2 2006 514 522 (Pubitemid 44576211)
111. C.E. Petrie Aronin, J.A. Cooper Jr., L.S. Sefcik, S.S. Tholpady, R.C. Ogle, and E.A. Botchwey Osteogenic differentiation of dura mater stem cells cultured in vitro on three-dimensional porous scaffolds of poly(epsilon- caprolactone) fabricated via co-extrusion and gas foaming Acta Biomater. 4 5 2008 1187 1197
112. N. Mohan, and P.D. Nair Polyvinyl alcohol-poly(caprolactone) semi IPN scaffold with implication for cartilage tissue engineering J. Biomed. Mater. Res. B Appl. Biomater. 84 2 2008 584 594
113. K.Y. Chang, L.W. Cheng, G.H. Ho, Y.P. Huang, and Y.D. Lee Fabrication and characterization of poly(gamma-glutamic acid)-graft-chondroitin sulfate/polycaprolactone porous scaffolds for cartilage tissue engineering Acta Biomater. 5 6 2009 1937 1947
114. E.D. Yildirim, H. Ayan, V. Vasilets, A. Fridman, S. Guceri, and W. Sun Effect of plasma treatment on osteoblastic adhesion over poly (ε-caprolactone) scaffolds Bioeng. Conf. 2008 2007 243 244
115. S. Sahoo, A. Sasmal, D. Sahoo, and P. Nayak Synthesis and characterization of chitosan-polycaprolactone blended with organoclay for control release of doxycycline J. Appl. Polym. Sci. 118 2010 3167 3175
116. S. Sahoo, A. Sasmal, R. Nanda, A.R. Phani, and P.L. Nayak Synthesis of chitosan-polycaprolactone blend for control delivery of ofloxacin drug Carbohydr. Polym. 79 2010 106 113
117. J. Zeng, X. Xu, X. Chen, Q. Liang, X. Bian, L. Yang, and X. Jing Biodegradable electrospun fibers for drug delivery J. Control. Release 92 3 2003 227 231 (Pubitemid 38366145)
118. J. Zeng, L. Yang, Q. Liang, X. Zhang, H. Guan, X. Xu, X. Chen, and X. Jing Influence of the drug compatibility with polymer solution on the release kinetics of electrospun fiber formulation J. Control. Release 105 1-2 2005 43 51 (Pubitemid 40805474)
119. H. Gao, Y. Gu, and Q. Ping The implantable 5-fluorouracil-loaded poly(l-lactic acid) fibers prepared by wet-spinning from suspension J. Control. Release 118 3 2007 325 332 (Pubitemid 46441552)
120. P.D. Dalton, J.L. Calvet, A. Mourran, D. Klee, and M. Moller Melt electrospinning of poly-(ethylene glycol-block-epsilon-caprolactone) Biotechnol. J. 1 9 2006 998 1006
121. Y. Wan, H. Wu, B. Xiao, X. Cao, and S. Dalai Chitosan-g-polycaprolactone copolymer fibrous mesh scaffolds and their related properties Polym. Adv. Technol. 20 2008 795 801
122. K.S. Yang, S.H. Park, Y.O. Choi, and C.S. Cho Fiber Formation from semi-interpenetrating polymer networks consisting of polycaprolactone and a poly(ethylene glycol) macromer J. Appl. Polym. Sci. 84 2002 835 841
123. I. Kotela, J. Podporska, E. Soltysiak, K.J. Konsztowicz, and M. Blazewicz Polymer nanocomposites for bone tissue substitutes Ceram. Int. 35 2009 2475 2480
124. D.H. Reneker, K. W., A. Theron, E. Zussman, and Y. A.L. Nanofiber garlands of polycaprolactone by electrospinning Polymer 43 2002 6785 6794 (Pubitemid 35252615)
125. H.I. Chang, Y.C. Lau, C. Yan, and A.G. Coombes Controlled release of an antibiotic, gentamicin sulphate, from gravity spun polycaprolactone fibers J. Biomed. Mater. Res. A 84 1 2008 230 237 (Pubitemid 350244264)
126. E.L. Van, L. Grondahl, K.N. Chua, K.W. Leong, V. Nurcombe, and S.M. Cool Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers Biomaterials 27 9 2006 2042 2050 (Pubitemid 41759498)
127. B. Mavis, T.T. Demirtas, M. Gumusderelioglu, G. Gunduz, and U. Colak Synthesis, characterization and osteoblastic activity of polycaprolactone nanofibers coated with biomimetic calcium phosphate Acta Biomater. 5 8 2009 3098 3111
128. K. Kanawung, K. Panitchanapan, S. Puangmalee, W. Utok, N. Kreua-Ongarjnukool, R. Rangkupan, C. Meechaisue, and P. Supaphol Preparation and characterization of polycaprolactone/diclofenac sodium and poly(vinyl alcohol)/tetracycline hydrochloride fiber mats and their release of the model drugs Polym. J. 39 4 2007 369 378 (Pubitemid 46877907)
129. M.R. Williamson, H.I. Chang, and A.G. Coombes Gravity spun polycaprolactone fibres: controlling release of a hydrophilic macromolecule (ovalbumin) and a lipophilic drug (progesterone) Biomaterials 25 20 2004 5053 5060 (Pubitemid 38520835)
130. A. Srivastava, T.V. Singh, S. Mule, C.R. Rajan, and S. Ponratham Study of chemical, optical and thermal modifications induced by 100 MeV silicon ions in a polycarbonate film Nucl. Instrum. Methods Phys. Res. B 192 2002 402
131. J. Pena, T. Corrales, I. Izquierdo-Barba, M.C. Serrano, M.T. Portoles, R. Pagani, and M. Vallet-Regi Alkaline-treated poly(epsilon-caprolactone) films: degradation in the presence or absence of fibroblasts J. Biomed. Mater. Res. A 76 4 2006 788 797 (Pubitemid 47233488)
132. O. Drevelle, E. Bergeron, H. Senta, M.A. Lauzon, S. Roux, G. Grenier, and N. Faucheux Effect of functionalized polycaprolactone on the behaviour of murine preosteoblasts Biomaterials 31 25 2010 6468 6476
133. H. Yavuz, and C. Babac Preparation and biodegradation of starch/polycaprolactone films J. Polym. Environ. 11 3 2003 107 113 (Pubitemid 38149291)
134. Y. Zhu, C. Gao, and J. Shen Surface modification of polycaprolactone with poly(methacrylic acid) and gelatin covalent immobilization for promoting its cytocompatibility Biomaterials 23 24 2002 4889 4895 (Pubitemid 35286712)
135. D. Simon, A. Holland, and R. Shanks Poly(caprolactone) thin film preparation, morphology, and surface texture J. Appl. Polym. Sci. 103 2007 1287 1294 (Pubitemid 46051281)
136. J. Pena, T. Corrales, I. Izquierdo-Barba, A.L. Doadrio, and M. Vallet-RegI Long term degradation of poly(3-caprolactone) films in biologically related fluids Polym. Degrad. Stab. 91 2006 1424 1432
137. G. Verreck, I. Chun, Y. Li, R. Kataria, Q. Zhang, J. Rosenblatt, A. Decorte, K. Heymans, J. Adriaensen, M. Bruining, M. Van Remoortere, H. Borghys, T. Meert, J. Peeters, and M.E. Brewster Preparation and physicochemical characterization of biodegradable nerve guides containing the nerve growth agent sabeluzole Biomaterials 26 11 2005 1307 1315 (Pubitemid 39314505)
138. J.H. Ashton, J.A. Mertz, J.L. Harper, M.J. Slepian, J.L. Mills, D.V. McGrath, and J.P. Vande Geest Polymeric endoaortic paving: mechanical, thermoforming, and degradation properties of polycaprolactone/polyurethane blends for cardiovascular applications Acta Biomater. 7 1 2011 287 294
139. Y. Ramgopal, D. Mondal, S.S. Venkatraman, W.T. Godbey, and G.Y. Yuen Controlled release of complexed DNA from polycaprolactone film: comparison of lipoplex and polyplex release J. Biomed. Mater. Res. B Appl. Biomater. 89B 2 2009 439 447
140. R. Shi, and H.M. Burt Amphiphilic dextran-graft-poly(epsilon- caprolactone) films for the controlled release of paclitaxel Int. J. Pharm. 271 1-2 2004 167 179 (Pubitemid 38210094)
141. D.S. Jones, J. Djokic, C.P. McCoy, and S.P. Gorman Poly(epsilon- caprolactone) and poly(epsilon-caprolactone)-polyvinylpyrrolidone-iodine blends as ureteral biomaterials: characterisation of mechanical and surface properties, degradation and resistance to encrustation in vitro Biomaterials 23 23 2002 4449 4458 (Pubitemid 36151596)
142. F. Quaglia, M. Vignola, G. De Rosa, M. La Rotonda, G. Maglio, and R. Palumbo New segmented copolymers containing poly(epsilon-caprolactone) and etheramide segments for the controlled release of bioactive compounds J. Control. Release 83 2 2002 263 271 (Pubitemid 35279471)
143. U. Olgun, K. Tunc, and V. Ozaslan Preparation of antimicrobial polycaprolactone-silica composite films with nanosilver rods and triclosan using roll-milling method Polym. Adv. Technol. 22 2 2009 232 236
144. A.P. Zhu, M.B. Chan-Park, and J.X. Gao Foldable micropatterned hydrogel film made from biocompatible PCL-b-PEG-b-PCL diacrylate by UV embossing J. Biomed. Mater. Res. B Appl. Biomater. 76 1 2006 76 84 (Pubitemid 43062747)
145. G. Gaucher, P. Satturwar, M.C. Jones, A. Furtos, and J.C. Leroux Polymeric micelles for oral drug delivery Eur. J. Pharm. Biopharm. 76 2 2010 147 158
146. G. Gaucher, M.H. Dufresne, V.P. Sant, N. Kang, D. Maysinger, and J.C. Leroux Block copolymer micelles: preparation, characterization and application in drug delivery J. Control. Release 109 1-3 2005 169 188 (Pubitemid 41742123)
147. S.C. Lee, C. Kim, I. Chan Kwon, H. Chung, and S. Young Jeong Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel J. Control. Release 89 3 2003 437 446 (Pubitemid 36555903)
148. Y. Qiu, and K. Park Environment-sensitive hydrogels for drug delivery Adv. Drug Deliv. Rev. 53 3 2001 321 339 (Pubitemid 34024913)
149. T.R. Hoare, and D.S. Kohane Hydrogels in drug delivery: progress and challenges Polymer 49 2008 1993 2007
150. S. Sharifi, H. Mirzadeh, M. Imani, Z. Rong, A. Jamshidi, M. Shokrgozar, M. Atai, and N. Roohpour Injectable in situ forming drug delivery system based on poly(epsilon-caprolactone fumarate) for tamoxifen citrate delivery: Gelation characteristics, in vitro drug release and anti-cancer evaluation Acta Biomater. 5 6 2009 1966 1978
151. K. Duan, X. Zhang, X. Tang, J. Yu, S. Liu, D. Wang, Y. Li, and J. Huang Fabrication of cationic nanomicelle from chitosan-graft-polycaprolactone as the carrier of 7-ethyl-10-hydroxy-camptothecin Colloids Surf. B Biointerfaces 76 2 2010 475 482
152. L.Y. Qiu, and Y.H. Bae Self-assembled polyethylenimine-graft- poly(epsilon-caprolactone) micelles as potential dual carriers of genes and anticancer drugs Biomaterials 28 28 2007 4132 4142 (Pubitemid 47048375)
153. P.L. Soo, J. Lovric, P. Davidson, D. Maysinger, and A. Eisenberg Polycaprolactone-block-poly(ethylene oxide) micelles: a nanodelivery system for 17beta-estradiol Mol. Pharm. 2 6 2005 519 527
154. E.K. Park, S.Y. Kim, S.B. Lee, and Y.M. Lee Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery J. Control. Release 109 1-3 2005 158 168 (Pubitemid 41737262)
155. X. Wei, C. Gong, S. Shi, S. Fu, K. Men, S. Zeng, X. Zheng, M. Gou, L. Chen, L. Qiu, and Z. Qian Self-assembled honokiol-loaded micelles based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer Int. J. Pharm. 369 1-2 2009 170 175
156. M.L. Forrest, J.A. Yanez, C.M. Remsberg, Y. Ohgami, G.S. Kwon, and N.M. Davies Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity Pharm. Res. 25 1 2008 194 206
157. H. Ge, Y. Hu, X. Jiang, D. Cheng, Y. Yuan, H. Bi, and C. Yang Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon- caprolactone) amphiphilic triblock copolymer micelles J. Pharm. Sci. 91 6 2002 1463 1473 (Pubitemid 34633962)
158. F. Danhier, N. Magotteaux, B. Ucakar, N. Lecouturier, M. Brewster, and V. Preat Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel Eur. J. Pharm. Biopharm. 73 2 2009 230 238
159. S. Aryal, S. Pilla, and S. Gong Multifunctional nano-micelles formed by amphiphilic gold-polycaprolactone-methoxy poly(ethylene glycol) (Au-PCL-MPEG) nanoparticles for potential drug delivery applications J. Nanosci. Nanotechnol. 9 10 2009 5701 5708
160. F. Ahmed, and D.E. Discher Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles J. Control. Release 96 1 2004 37 53 (Pubitemid 38438488)
161. L. Cheng, S. Guo, and W. Wu Characterization and in vitro release of praziquantel from poly(epsilon-caprolactone) implants Int. J. Pharm. 377 1-2 2009 112 119
162. T. Tanaka, S. Eguchi, H. Saitoh, M. Taniguchi, and D.R. Lloyd Microporous foams of polymer blends of poly(L-lactic acid) and poly(ε-caprolactone) Desalination 234 2008 175 183
163. M.J. Jenkins, K.L. Harrison, M.M.C.G. Silva, M.J. Whitaker, K.M. Shakesheff, and S.M. Howdle Characterisation of microcellular foams produced from semi-crystalline PCL using supercritical carbon dioxide Eur. Polym. J. 42 2006 3145 3151 (Pubitemid 44572295)
164. C.I. Winternitz, J.K. Jackson, A.M. Oktaba, and H.M. Burt Development of a polymeric surgical paste formulation for taxol Pharm. Res. 13 3 1996 368 375 (Pubitemid 26114726)
165. P.P. Ghoroghchian, G. Li, D.H. Levine, K.P. Davis, F.S. Bates, D.A. Hammer, and M.J. Therien Bioresorbable vesicles formed through spontaneous self-assembly of amphiphilic poly(ethylene oxide)-blockpolycaprolactone Macromolecules 39 5 2006 1673 1675
166. Alveolar ridge preservation with polycaprolactone scaffold for implant site development National University Hospital, Singapore. Pub. Clinicaltrials.gov 2010 july 15
167. C.C. Chung, Local drug delivery film for periodontal pocket, U.S. Patent 005599553 A, Feb 4, 1997.
168. P. Calias, R.J. Miller, J.R. Olson, Drug delivery of proteins from polymeric blends, U.S. Patent 2002/0182254 A1, Dec 5, 20002.
169. D.Q.M. Carig, J.A. McNally, Nano-composite drug delivery composition, U.S. Patent 2006/0147538 A1, Jul 6, 2006.
170. L.B. Jungherr, T.B. Ottoboni, Occular microsphere delivery system, U.S. Patent 005837226, Nov 17, 1998.
171. X. Zhao, Multi-arm block copolymers as drug delivery vehicles, U.S. Patent 2009/0299050 A1, Dec 3, 2009.